By Guy Gin | Making (Covid) Waves in Japan | October 21, 2022 Last month, Japanese pharma company Kowa put out a press release of the results of its 1030-person double-blind randomised control trial (RCT) of Ivermectin conducted at 54 institutions in Japan and 2 in Thailand. Here’s how the results were reported in The Japan Times. Not […]
Source